-
SpeichernDas Eingabefeld wird
gespeichert wenn Sie das Feld
verlassen oder hier klicken.Börse NasdaqISIN US69404D1081
PACIFIC BIOSCIEN outperformed den DAX um +99 % vom 06.05.2014 bis 02.10.2020
Die letzten Quartalsergebnisse Erwarteter Gewinn je Aktie beim aktuellen Wert von 37,01 USD +7,74%
Portrait der Aktie: PACIFIC BIOSCIEN
Das Unternehmen PACIFIC BIOSCIEN aus USA beschäftigt 769 Mitarbeiter und ist in den Bereichen Chemie & Pharma, Biotechnologie tätig.
Die PACIFIC BIOSCIEN Aktie konnte seit dem 06.05.2014 eine Rendite von 130% erwirtschaften.
PACIFIC BIOSCIEN ist nur in 9 ETFs enthalten und somit eine nicht sonderlich bekannte oder beliebte Aktie. Der Spitzenreiter Global X Genomics & Biotechnology ETF gewichtet PACIFIC BIOSCIEN mit 3,35% im ETF.
Entdecke die 6 ETFs in denen PACIFIC BIOSCIEN am höchsten gewichtet ist Insgesamt in 9 ETFs enthalten
Dir gefallen die Informationen zu PACIFIC BIOSCIEN?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn Ihr meine Arbeit unterstützen möchtet, dann eröffnet gerne ein kostenloses und unverbindliches Depot bei Trade Republic mit der Möglichkeit kostenlos Aktien zu besparen. Wenn du das über meinen Link machst, bekommst du und ich bei deinem ersten Wertpapierkauf 15 von Trade Republic geschenkt:
Dir gefallen die Informationen zu PACIFIC BIOSCIEN?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn du meine Arbeit unterstützen möchtest, dann eröffne ein kostenloses und unverbindliches Depot bei BUX Zero mit der Möglichkeit kostenlos US-Aktien und für einen Euro viele weitere Aktien aus Deutschland, Belgien, Niederlande, sterreich oder UK zu kaufen. Wenn du das über meinen Link machst, bekommen wir beide eine gratis Aktie geschenkt:
Dir gefallen die Informationen zu PACIFIC BIOSCIEN?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn du meine Arbeit unterstützen möchtest, dann eröffne gerne ein kostenloses und unverbindliches Depot bei der ING Diba. Ich erhalte 20 wenn du daraufhin dann zum Beispiel einen Aktien-Sparplan anlegst oder etwas kaufst:
Dir gefallen die Informationen zu PACIFIC BIOSCIEN?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn Ihr meine Arbeit unterstützen möchtet, dann eröffnet gerne ein mindestens 3 Jahre lang kostenloses Depot bei der comdirect. Wenn du das über diesen Link machst unterstützt du auch meine Tochter Zoe, da es Ihr Juniordepot ist. Sie erhält 20 und bei einem aktiven ETF- oder Aktien-Sparplan bleibt dein Depot auch danach kostenfrei:
45 News & Informationen zur PACIFIC BIOSCIEN Aktie
Is Pacific Biosciences (PACB) A Smart Long-Term Buy?
DEVON Equity Management, an investment management firm, published its “Global Opportunities Fund” second quarter 2021 investor letter – a copy of which can be downloaded here.
Pacific Biosciences of California (PACB) Reports Q2 Loss, Tops Revenue Estimates
Pacific Biosciences (PACB) delivered earnings and revenue surprises of -5.00% and 0.49%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?
A Leading High Molecular Weight DNA Extraction Company
MENLO PARK, Calif., Aug. 03, 2021 (GLOBE NEWSWIRE) — Pacific Biosciences of California, Inc. (Nasdaq: PACB) (“Pacific Biosciences” or “PacBio”), a leading
Pacific Biosciences Acquires Circulomics – A Leading High Molecular Weight DNA Extraction Company
MENLO PARK, Calif., Aug. 03, 2021 (GLOBE NEWSWIRE) — Pacific Biosciences of California, Inc. (NASDAQ:PACB) (“Pacific Biosciences” or “PacBio”), a leading …
5 Most Profitable Holdings of Catherine Wood's ARK
GuruFocus Article or News written by Graham Griffin and the topic is about: Unique investments racking up large profits
3 Things About Illumina That Smart Investors Know
The company is cemented as the industry leader, but a crack is showing.
TFC Financial Management Buys iShares Core MSCI International Developed Markets , Broadstone Net Lease Inc, iShares Global REIT ETF, Sells SPDR Bloomberg Barclays 1-3 Month T-Bill ETF, NextEra Energy
GuruFocus Article or News written by insider and the topic is about:
Earnings Preview: Pacific Biosciences of California (PACB) Q2 Earnings Expected to Decline
Pacific Biosciences (PACB) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Next Generation Sequencing Market Size Worth USD 20,347.45 Million by 2025 at 18.05% CAGR – Report by Market Research Future (MRFR)
Next-Generation Sequencing Market Insights and Industry Analysis by Technology (Targeted Sequencing & Resequencing, Whole Genome Sequencing and Whole Exome…
Cathie Wood’s ARK Invest Buys Over 800,000 Shares of Quantum-Si – 24/7 Wall St.
One of Cathie Wood's Ark Invest funds bought over 800,000 shares of Quantum-Si on July 22.
Cathie Wood’s ARK Invest Buys for 7
Here's a look at the ARK Invest buys for July 22, 2021.
Cathie Wood’s ARK Invest Buys Over 600,000 Shares of DraftKings – 24
A couple of Cathie Wood's ARK Invest funds bought over 600,000 shares of DraftKings on July 21.
Here is What Hedge Funds Think About Pacific Biosciences of California, Inc. (PACB)
Is Pacific Biosciences of California, Inc. (NASDAQ:PACB) a good place to invest some of your money right now? We can gain invaluable insight to help us…
Pacific Biosciences and Invitae Announce Intent to Expand Collaboration
Collaboration to develop production-scale HiFi Sequencing platformexpected to Include technology from Omniome, Inc. Combining both highly accurate long…
Should I Buy Littelfuse, Inc. (LFUS)?
Hedge funds and large money managers usually invest with a focus on the long-term horizon and, therefore, short-lived dips or bumps on the charts usually…
Worldwide Long-Read Sequencing Industry to 2030 – Decreasing Cost of Sequencing is Driving Growth
/PRNewswire/ — The “Global Long-Read Sequencing Market: Focus on Products and Services, Technology, Application, End User, Country Data (17 Countries), and…
Worldwide Long-Read Sequencing Industry to 2030 – Decreasing Cost of Sequencing is Driving Growth
DUBLIN, July 16, 2021 /PRNewswire/ — The 'Global Long-Read Sequencing Market: Focus on Products and Services, Technology, Application, End User, …
Worldwide Gene Expression Analysis Industry To 2026 – Key Players Include GE Healthcare, Oxford Gene Technology And Qiagen
DUBLIN, July 15, 2021 /PRNewswire/ — The “Gene Expression Analysis Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026”
Hedge Funds Have Never Been This Bullish On Life Storage, Inc. (LSI)
Our extensive research has shown that imitating the smart money can generate significant returns for retail investors, which is why we track nearly 900…
Avitas Wealth Management LLC Buys Marathon Petroleum Corp, Signature Bank, Freeport-McMoRan Inc, Sells Best Buy Co Inc, Autodesk Inc, Delta Air Lines Inc
GuruFocus Article or News written by insider and the topic is about:
3 Cathie Wood Stocks You Can Buy for Less Than $50
You can get a lot of bang for the buck with these picks.
Where Will ARK Genomic Revolution ETF Be in 5 Years?
Cathie Wood's genomics ETF is making big bets on the
The Worldwide Precision Medicine Industry is Expected to Reach $738.8 Billion by 2030
DUBLIN, July 7, 2021 /PRNewswire/ — The 'Precision Medicine Market Research Report: By Type (Therapeutics, Diagnostics, Personalized Medical Care…
JetBlue Airways Corporation (JBLU) Fell Out Of Favor With Hedge Funds?
The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data….
Insights on the Long Read Sequencing Global Market to 2028 – by Technology, Product, Application, Workflow, End-user and Geography
/PRNewswire/ — The “Long Read Sequencing Market Forecast to 2028 – COVID-19 Impact and Global Analysis By Technology, Product, Application, Workflow, End User…
10 Best Tech Stocks to Buy According to Japanese Billionaire Masayoshi Son
In this article, we discuss the 10 best tech stocks to buy according to Japanese billionaire Masayoshi Son. If you want to skip our detailed analysis…
Here is What Hedge Funds Think About Angi Inc. (ANGI)
Last year we predicted the arrival of the first US recession since 2009 and we told in advance that the market will decline by at least 20% in (Recession…
Pacific Biosciences and Rady Children's Institute for Genomic Medicine Announce its First Research Collaboration for Whole Genome Sequencing
MENLO PARK, Calif., June 23, 2021 — Pacific Biosciences of California, Inc. , a leading provider of high-quality, long-read sequencing platforms, and Rady Children’s Institute for… | June 23, 2021
Pacific Biosciences And Rady Children's Institute For Genomic Medicine Announce Its First Research Collaboration For Whole Genome Sequencing
MENLO PARK, Calif., June 23, 2021 (GLOBE NEWSWIRE) — Pacific Biosciences of California, Inc. (Nasdaq: PACB)(“Pacific Biosciences” or “PacBio”), a leading
Why Invitae Stock Flew Higher Today
Investors appear to like the company's new collaboration with PacBio.
Cramer Shares His Thoughts On Kodak, Apple And More
On CNBC's
EDGAR Filing Documents for 0001562762-21-000009
Pacific Biosciences Grants Equity Incentive Awards to New Employees
MENLO PARK, Calif., Jan. 12, 2021 (GLOBE NEWSWIRE) — Pacific Biosciences of California, Inc. (NASDAQ: PACB) (“Pacific Biosciences” or the “Company”), a…
SoftBank Takes Stake in DNA Firm Pacific Biosciences
(Bloomberg) — SoftBank Group Corp. has taken a stake of about 6% in Pacific Biosciences of California Inc., a U.S. DNA-sequencing company whose stock has risen sevenfold in the last year, according to a person with knowledge of the investment.
Portfolio Manager Thinks Gene-Editing Stocks Could Outperform Tesla
Portfolio Manager Thinks Gene-Editing Stocks Could Outperform Tesla, Stocks: TSLA,EDIT,CRSP,NTLA,ARKG,PACB,FATE,NVTA,IOVA,EXAS, release date:Jan 08, 2021
Wellcome Sanger Institute Increases Investment in PacBio Long-Read Sequencing to Support Darwin Tree of Life Research Initiative
MENLO PARK, Calif ., Jan. 08, 2021 (GLOBE NEWSWIRE) — Pacific Biosciences of California, Inc. (NASDAQ:PACB), a leading provider of high-quality, long-read …
The Daily Biotech Pulse: Sarepta Gene Therapy Study Readout, Novavax Vaccine Supply Deal, 2 IPOs
Here's a roundup of top developments in the biotech space over the last 24 hours.
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs Jan. 7) …
Global Oncology Precision Medicine Market (2020 to 2030) – Analysis and Forecast
Dublin, Jan. 05, 2021 (GLOBE NEWSWIRE) — The “Global Oncology Precision Medicine Market: Focus on Application Area, Ecosystem Type, Country Data (15 …